Flexor pollicis longus tenosynovitis caused by Mycobacterium marinum infection.

To cite: Iyengar KP, Matar HE, Jayeola AO, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/ bcr-2014-205443 DESCRIPTION Among infections of the hand, Mycobacterium marinum accounts for 0.04–0.27/100 000 cases; most are caused by superficial abrasions from water and other environmental sources. M. marinum has an extensive habitat and lives in a warm aquatic environment, optimally cultured at a temperature of 25–35°C. There are no pathognomonic features of M. marinum infections, with diverse presenting symptoms. These infections are categorised into three types: self-limiting verrucal lesions; subcutaneous granulomas; and deep infections involving the tenosynovium, bursa, bones or joints causing tenosynovitis, septic arthritis or osteomyelitis. Delay in making diagnosis is common due to a long inoculation period ranging from few days to few months. Initial clinical and radiological findings are often non-specific; diagnosis is confirmed by positive microbiological cultures. Treatment is by antimicrobial and surgical debridement and synovectomy of deep infections followed by an extensive rehabilitation programme to regain hand function. We present an interesting case of flexor pollicis longus (FPL) tenosynovitis caused by M. marinum in a normally fit and well 38-year-old right handed woman. She sustained a superficial abrasion to her right thumb while filleting salmon at home. This turned into a painful swelling which was mistaken for cellulitis, resisting broad-spectrum antibiotics (oral co-amoxiclav in primary care settings; intravenous piperacillin/tazobactam and metronidazole in hospital care). Plain radiographs (figure 1) demonstrated soft tissue swellings; however, MRI confirmed FPL tenosynovitis (figure 2). The patient proceeded with surgical debridement and extended cultures of tissue specimens confirmed M. marinum infection sensitive to azithromycin, clarithromycin, gentamicin and tobramycin. She received a 6-month course of oral clarithromycin 500 mg twice daily and clofazimine 50 mg once daily. A targeted hand therapy programme led to eventual successful functional recovery.